Publications by authors named "B J Rimel"

Claim this Profile
T
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.
Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann, Brandie C Taylor, Julia D Wulfkuhle, B J Rimel

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory evaluation of the somatic and immunologic landscape of primary and metastatic cervical cancer to better inform future clinical trial development.
Victoria Cerda, Bobbie J Rimel, Jacob Mercer, Michael A Thompson, Denise Shieh

Int J Gynecol Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer.
B J Rimel, Eric Pujade-Lauraine, Kathleen Moore, Jacobus Pfisterer, Sileny Han

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour extracellular vesicle surface Protein-mRNA integration assay for early detection of epithelial ovarian cancer.
Ying-Tzu Yen, Chen Zhao, Tian Gao, Jacqueline Ziqian Yang, Ning Kang, Bobbie J Rimel

EBioMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and breaking barriers: Addressing disparities in the care of patients with gynecologic cancers.
Bhavana Pothuri, Michele Muir, Jean Hurteau, John Farley, Michelle D S Lightfoot, B J Rimel

Gynecol Oncol Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis